Drug
LU Ah69593
LU Ah69593: highest development phase Phase 1, developed by Lundbeck. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Lundbeck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lu AH69593 NCT07775261 | Phase 1 | |
| Lu AH69593 NCT07613710 | Phase 1 | Narcolepsy |
Latest
No recent events.
Follow LU Ah69593 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.